The Clorox Company (CLX) Key Metrics
CLX valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $10.53B
- Enterprise value
- $15.53B
- P/E (TTM)
- 18.1 10-yr median 27.4
- Forward P/E
- 14.9
- PEG ratio
- 1.09
- Price / sales
- 1.6 10-yr median 2.8
- Price / book
- 117.1 10-yr median 33.5
- EV / EBITDA
- 13.3 10-yr median 19.0
- Dividend yield
- 5.74% $5.00 a year
- Beta
- 0.57
CLX key metrics, FY2017–FY2026
Fiscal year ended June 30, 2026 · U.S. dollarsCLX valuation Price multiples at each fiscal year-end price.
CLX returns How much profit the business earns on the capital it uses.
CLX per-share figures Results divided by the shares outstanding at year-end.
CLX financial health Debt, liquidity and how easily interest is covered.
CLX efficiency & capital use Working capital cycle and where the cash goes.
CLX valuation history
CLX returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CLX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CLX cash returned to shareholders
CLX price vs earnings per share
CLX key metrics
FY2017–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $11.66B | $14.92B | $17.03B | $19.75B | $17.47B | $22.90B | $28.01B | $19.87B | $17.80B | $17.53B |
| Enterprise value | $17.03B | $17.64B | $19.73B | $22.31B | $20.39B | $25.75B | $30.26B | $22.44B | $20.15B | $19.31B |
| P/E ratio | 19.9 | 18.4 | 60.8 | 132.5 | 37.8 | 32.3 | 29.8 | 24.2 | 21.6 | 25.0 |
| Price / sales | 1.7 | 2.1 | 2.4 | 2.7 | 2.5 | 3.1 | 4.2 | 3.2 | 2.9 | 2.9 |
| Price / book | 129.5 | 31.0 | 34.6 | 50.9 | 24.0 | 38.7 | 30.8 | 35.6 | 24.5 | 32.3 |
| Price / free cash flow | 28.8 | 19.6 | 35.3 | 21.2 | 32.7 | 24.2 | 21.7 | 25.3 | 22.8 | 27.5 |
| Price / operating cash flow | 19.0 | 15.2 | 24.5 | 17.1 | 22.2 | 17.9 | 18.1 | 20.0 | 18.3 | 20.2 |
| EV / sales | 2.5 | 2.5 | 2.8 | 3.0 | 2.9 | 3.5 | 4.5 | 3.6 | 3.3 | 3.2 |
| EV / EBITDA | 14.6 | 12.7 | 27.3 | 39.6 | 21.8 | 21.3 | 20.7 | 17.3 | 15.4 | 15.0 |
| EV / free cash flow | 42.1 | 23.2 | 40.9 | 24.0 | 38.1 | 27.2 | 23.4 | 28.6 | 25.8 | 30.3 |
| Earnings yield | 5.0% | 5.4% | 1.6% | 0.8% | 2.6% | 3.1% | 3.4% | 4.1% | 4.6% | 4.0% |
| Free cash flow yield | 3.5% | 5.1% | 2.8% | 4.7% | 3.1% | 4.1% | 4.6% | 4.0% | 4.4% | 3.6% |
| Dividend yield | 5.2% | 4.0% | 3.5% | 3.0% | 3.3% | 2.4% | 1.9% | 2.5% | 2.5% | 2.4% |
| Shareholder yield (dividends + buybacks) | 7.4% | 6.3% | 3.5% | 3.0% | 3.4% | 6.4% | 2.8% | 5.8% | 4.1% | 3.4% |
| Share price at fiscal year-end | $95.44 | $120.07 | $136.47 | $159.04 | $140.98 | $179.91 | $219.37 | $153.11 | $135.25 | $133.24 |
| Per share | ||||||||||
| Revenue per share | $55.02 | $57.16 | $56.83 | $59.50 | $57.36 | $57.67 | $52.64 | $47.88 | $46.54 | $45.40 |
| Earnings per share | $4.81 | $6.52 | $2.24 | $1.20 | $3.73 | $5.58 | $7.35 | $6.32 | $6.25 | $5.33 |
| Operating cash flow per share | $5.01 | $7.89 | $5.57 | $9.33 | $6.34 | $10.02 | $12.11 | $7.64 | $7.40 | $6.60 |
| Free cash flow per share | $3.32 | $6.12 | $3.87 | $7.49 | $4.32 | $7.42 | $10.12 | $6.06 | $5.93 | $4.84 |
| Cash per share | $1.17 | $1.34 | $1.62 | $2.96 | $1.48 | $2.51 | $6.82 | $0.86 | $1.00 | $3.18 |
| Book value per share | $0.74 | $3.88 | $3.94 | $3.12 | $5.88 | $4.65 | $7.11 | $4.31 | $5.52 | $4.12 |
| Tangible book value per share | −$20.15 | −$10.56 | −$11.35 | −$12.69 | −$13.82 | −$14.93 | −$12.24 | −$14.98 | −$13.72 | −$10.46 |
| Dividends per share | $4.93 | $4.84 | $4.77 | $4.69 | $4.61 | $4.38 | $4.17 | $3.78 | $3.42 | $3.13 |
| Capex per share | $1.69 | $1.77 | $1.70 | $1.84 | $2.03 | $2.60 | $1.99 | $1.59 | $1.47 | $1.76 |
| Debt per share | $45.20 | $23.17 | $23.26 | $23.55 | $25.04 | $24.87 | $24.45 | $20.67 | $18.87 | $16.68 |
| Shares outstanding | 122.1M | 124.3M | 124.8M | 124.2M | 123.9M | 127.3M | 127.7M | 129.8M | 131.6M | 131.6M |
| Change in shares outstanding | −1.7% | −0.4% | +0.5% | +0.2% | −2.7% | −0.3% | −1.6% | −1.4% | +0.0% | −0.1% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 205.2% | 166.3% | 63.6% | 26.7% | 69.9% | 94.7% | 128.0% | 127.6% | 129.8% | 167.1% |
| Return on invested capital (ROIC) | 29.2% | 28.2% | 17.3% | 16.9% | 15.7% | 29.7% | 31.8% | 28.6% | 32.6% | 33.6% |
| Return on assets (ROA) | 8.8% | 14.3% | 4.8% | 2.5% | 7.4% | 11.3% | 16.6% | 16.1% | 17.1% | 15.4% |
| Return on tangible assets | 11.2% | 21.5% | 7.3% | 3.7% | 12.4% | 18.5% | 25.1% | 31.4% | 32.5% | 26.4% |
| Free cash flow margin | 6.0% | 10.7% | 6.8% | 12.6% | 7.5% | 12.9% | 19.2% | 12.6% | 12.7% | 10.7% |
| Income quality (OCF / net income) | 1.04 | 1.21 | 2.48 | 7.77 | 1.70 | 1.80 | 1.65 | 1.21 | 1.18 | 1.24 |
| Financial health | ||||||||||
| Total debt | $5.52B | $2.88B | $2.90B | $2.92B | $3.10B | $3.17B | $3.12B | $2.68B | $2.48B | $2.19B |
| Cash & short-term investments | $143.0M | $167.0M | $202.0M | $367.0M | $183.0M | $319.0M | $871.0M | $111.0M | $131.0M | $418.0M |
| Net debt | $5.38B | $2.71B | $2.70B | $2.56B | $2.92B | $2.85B | $2.25B | $2.57B | $2.35B | $1.78B |
| Debt / equity | 61.33 | 5.98 | 5.90 | 7.54 | 4.26 | 5.35 | 3.44 | 4.80 | 3.42 | 4.05 |
| Debt / assets | 0.71 | 0.52 | 0.50 | 0.49 | 0.50 | 0.50 | 0.50 | 0.52 | 0.49 | 0.48 |
| Net debt / EBITDA | 4.60 | 1.96 | 3.74 | 4.53 | 3.12 | 2.35 | 1.54 | 1.98 | 1.80 | 1.38 |
| Current ratio | 0.66 | 0.84 | 1.03 | 0.95 | 0.97 | 0.89 | 1.42 | 0.91 | 1.09 | 0.84 |
| Quick ratio | 0.38 | 0.57 | 0.63 | 0.59 | 0.54 | 0.52 | 1.10 | 0.55 | 0.67 | 0.58 |
| Interest coverage | 12.8 | 13.4 | 8.0 | 9.1 | 6.8 | 12.4 | 12.7 | 11.4 | 13.2 | 12.7 |
| Working capital | −$949.0M | −$311.0M | $48.0M | −$89.0M | −$59.0M | −$227.0M | $602.0M | −$135.0M | $111.0M | −$295.0M |
| Invested capital | $5.47B | $3.19B | $3.19B | $2.94B | $3.65B | $3.44B | $3.16B | $3.13B | $3.08B | $2.32B |
| Tangible asset value | −$2.30B | −$1.31B | −$1.42B | −$1.58B | −$1.71B | −$1.90B | −$1.56B | −$1.94B | −$1.80B | −$1.38B |
| Net current asset value | −$5.72B | −$3.47B | −$3.64B | −$3.73B | −$3.70B | −$3.91B | −$3.29B | −$3.25B | −$3.02B | −$2.52B |
| Graham number | $8.93 | $23.85 | $14.11 | $9.18 | $22.22 | $24.16 | $34.31 | $24.74 | $27.87 | $22.22 |
| Graham net-net per share | −$52.54 | −$32.46 | −$33.79 | −$34.84 | −$35.17 | −$36.09 | −$29.15 | −$28.64 | −$26.60 | −$22.50 |
| Capital allocation | ||||||||||
| Dividends paid | $602.0M | $602.0M | $595.0M | $583.0M | $571.0M | $558.0M | $533.0M | $490.0M | $450.0M | $412.0M |
| Share buybacks (net) | $256.0M | $332.0M | $0 | $0 | $25.0M | $905.0M | $248.0M | $661.0M | $271.0M | $183.0M |
| Dividend payout ratio | 102.6% | 74.3% | 212.5% | 391.3% | 123.6% | 78.6% | 56.8% | 59.8% | 54.7% | 58.8% |
| Dividends + buybacks / free cash flow | 211.9% | 122.7% | 123.2% | 62.7% | 111.4% | 154.8% | 60.4% | 146.4% | 92.4% | 93.4% |
| Capex / revenue | 3.1% | 3.1% | 3.0% | 3.1% | 3.5% | 4.5% | 3.8% | 3.3% | 3.2% | 3.9% |
| Capex / operating cash flow | 33.8% | 22.4% | 30.5% | 19.7% | 31.9% | 25.9% | 16.4% | 20.8% | 19.9% | 26.6% |
| Capex / depreciation | 0.84 | 1.00 | 0.90 | 0.97 | 1.12 | 1.57 | 1.41 | 1.14 | 1.17 | 1.42 |
| Stock-based compensation / revenue | 0.7% | 1.1% | 1.0% | 1.0% | 0.7% | 0.7% | 0.7% | 0.7% | 0.9% | 0.9% |
| R&D / revenue | 1.7% | 1.7% | 1.8% | 1.9% | 1.9% | 2.0% | 2.2% | 2.2% | 2.2% | 2.3% |
| SG&A / revenue | 15.9% | 26.7% | 30.6% | 25.9% | 23.4% | 24.4% | 24.5% | 23.6% | 23.0% | 23.6% |
| Efficiency | ||||||||||
| Days sales outstanding | 43.8 | 38.9 | 35.6 | 33.8 | 33.0 | 31.1 | 34.7 | 36.2 | 34.7 | 34.6 |
| Days of inventory on hand | 61.2 | 54.4 | 60.1 | 59.1 | 60.3 | 53.1 | 48.2 | 53.3 | 51.1 | 49.9 |
| Days payables outstanding | 114.8 | 83.9 | 88.9 | 80.7 | 75.6 | 66.3 | 54.0 | 53.1 | 53.3 | 54.8 |
| Cash conversion cycle (days) | -9.8 | 9.5 | 6.8 | 12.2 | 17.7 | 18.0 | 28.9 | 36.4 | 32.4 | 29.7 |
| Receivables turnover | 8.34 | 9.37 | 10.26 | 10.79 | 11.06 | 11.73 | 10.51 | 10.10 | 10.51 | 10.53 |
| Payables turnover | 3.18 | 4.35 | 4.10 | 4.52 | 4.83 | 5.50 | 6.76 | 6.88 | 6.84 | 6.66 |
| Inventory turnover | 5.96 | 6.71 | 6.07 | 6.18 | 6.05 | 6.87 | 7.57 | 6.85 | 7.15 | 7.32 |
| Asset turnover | 1.01 | 1.26 | 1.21 | 1.22 | 1.14 | 1.17 | 1.19 | 1.22 | 1.27 | 1.31 |
| Average receivables | $806.0M | $758.0M | $691.5M | $684.5M | $642.5M | $626.0M | $639.5M | $615.5M | $582.5M | $567.0M |
| Average payables | $1.22B | $894.0M | $985.5M | $990.5M | $945.0M | $752.5M | $541.0M | $507.0M | $504.0M | $495.5M |
| Average inventory | $650.0M | $580.0M | $666.5M | $725.5M | $753.5M | $603.0M | $483.0M | $509.0M | $482.5M | $451.0M |
| Intangibles / total assets | 32.7% | 32.3% | 33.2% | 33.0% | 39.7% | 39.4% | 39.8% | 48.9% | 50.0% | 41.9% |
Computed from CLX's annual financial statements (latest annual report filed August 7, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CLX valuation and financial ratios
At the end of fiscal 2026 (June 30, 2026), Clorox traded at 19.9 times earnings, against a 10-year median of 27.4. Based on the latest twelve months, the trailing P/E is 18.1 and the forward P/E is 14.9. Clorox earned a return on equity of 205.2% and a return on invested capital of 29.2% in fiscal 2026. It ended the year with $5.5 billion of debt and $143.0 million in cash and short-term investments, net debt of $5.4 billion. It returned $858.0 million to shareholders: $602.0 million in dividends and $256.0 million in share buybacks, 212% of free cash flow. The share count fell 7.2% from 131.6M to 122.1M over 9 years.
See the CLX income statement, the CLX chart for price history, or the CLX stock overview for the latest quote and news.
CLX key metrics FAQ
What is Clorox's P/E ratio?
Clorox's trailing P/E ratio is 18.1 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 14.9. At the end of fiscal 2026 it was 19.9, compared with a 10-year median of 27.4.
What is Clorox's EV/EBITDA?
Clorox's enterprise value was 14.6 times EBITDA at the end of fiscal 2026 (enterprise value $17.0 billion, EBITDA $1.2 billion); the current EV/EBITDA is 13.3.
What is Clorox's return on equity?
Clorox's return on equity (ROE) was 205.2% in fiscal 2026: net income of $587.0 million on average shareholders' equity of $286.0 million. ROE is high partly because years of buybacks have reduced equity on the balance sheet.
What is Clorox's ROIC?
Clorox's return on invested capital was 29.2% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Clorox have?
Clorox had total debt of $5.5 billion at the end of fiscal 2026, a debt-to-equity ratio of 61.33 and $5.4 billion of net debt (4.60 times EBITDA).
What is Clorox's dividend yield?
Clorox's forward dividend yield is 5.74%. Clorox paid $602.0 million in dividends in fiscal 2026 ($4.93 per share), a payout ratio of 102.6%.
Does Clorox buy back its shares?
Yes. Clorox spent $256.0 million on net share repurchases in fiscal 2026 Shares outstanding changed −1.7% over the year, to 122.1M..
What is Clorox's free cash flow yield?
Clorox generated $405.0 million of free cash flow in fiscal 2026, a free cash flow yield of 3.5% on its market value at year-end ($11.7 billion).
What is Clorox's current ratio?
Clorox's current ratio was 0.66 at the end of fiscal 2026: current assets were 0.66 times current liabilities.